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Abstract
Human immunodeficiency virus type 1 (HIV-1) exploits a diverse array of host cell functions in order to replicate. This is
mediated through a network of virus-host interactions. A variety of recent studies have catalogued this information. In
particular the HIV-1, Human Protein Interaction Database (HHPID) has provided a unique depth of protein interaction detail.
However, as a map of HIV-1 infection, the HHPID is problematic, as it contains curation error and redundancy; in addition, it
is based on a heterogeneous set of experimental methods. Based on identifying shared patterns of HIV-host interaction, we
have developed a novel methodology to delimit the core set of host-cellular functions and their associated perturbation
from the HHPID. Initially, using biclustering, we identify 279 significant sets of host proteins that undergo the same types of
interaction. The functional cohesiveness of these protein sets was validated using a human protein-protein interaction
network, gene ontology annotation and sequence similarity. Next, using a distance measure, we group host protein sets
and identify 37 distinct higher-level subsystems. We further demonstrate the biological significance of these subsystems by
cross-referencing with global siRNA screens that have been used to detect host factors necessary for HIV-1 replication, and
investigate the seemingly small intersect between these data sets. Our results highlight significant host-cell subsystems that
are perturbed during the course of HIV-1 infection. Moreover, we characterise the patterns of interaction that contribute to
these perturbations. Thus, our work disentangles the complex set of HIV-1-host protein interactions in the HHPID, reconciles
these with siRNA screens and provides an accessible and interpretable map of infection.
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Introduction
Acquired immunodeficiency syndrome (AIDS), caused by HIV-
1, is responsible for millions of deaths every year. Therefore,
research into HIV-1 biology is of critical importance and research
efforts are significant and ongoing. In order to replicate, HIV-1,
like all viruses, must use host-cellular machinery and induce
production of viral genomic material, viral proteins and ultimately
new virions. This hijack and control over host cell processes is
mediated by HIV-1 proteins through a complex network of
molecular events, including virus-host protein-protein interactions
(PPIs) [1]. Therefore, by developing our knowledge of the virus-
host interaction network, we can improve our current model of
HIV-1 infection and host-cell perturbation and use this informa-
tion to aid development of new antiviral treatments. One example
of a successful antiviral treatment that has come from under-
standing HIV-host cell interaction is the drug maraviroc [2].
Maraviroc is an entry-inhibitor that binds the CCR5 co-receptor,
inhibiting gp120:CD4:CCR5 complex formation and, thus, entry
into the host cell. Targeting a host protein in this way
demonstrates that the number of possible HIV-1 therapeutic drug
targets is not limited to the small viral proteome and that
understanding the virus-host interface can lead to the development
of novel-acting therapeutic agents.
Our knowledge of HIV-1-host PPIs is extensive in relation to
other pathogens [3]. A major source of HIV-1-host protein
interaction data is the HIV-1, Human Protein Interaction
Database (HHPID) [1,4,5]. This database holds over 5000
interactions involving over 1400 human proteins, curated from
primary literature on small-scale protein interaction studies. In the
HHPID, an impressive level of detail is recorded, including a short
description of each interaction outcome, e.g., ‘phosphorylates’,
‘binds’, ‘activates’ etc. However, there are several problems
associated with this data set:
(i) Interactions in the HHPID come from a large number of
separate publications over a wide date range and are
derived from a diverse array of experimental procedures,
such that the quality of the data is varied and the
proportion of false-positive interactions, though presum-
ably minimised by the small-scale nature of the contrib-
uting works, is difficult to estimate.
(ii) The manual curation step introduces a potential for
inconsistency and some anomalies have been identified [6].
(iii) The database contains a large amount of redundant data,
where the same interaction has been reported more than
once in two separate records. For example, in the HHPID
there are 27 entries describing interaction between the
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including five that describe binding and five more that
describe complexing, two describing activation and three
describing stimulation, although from these data it is not
clear whether more than one interaction actually occurs.
(iv) A second level of redundancy exists due to downstream
consequences of interactions. For example, the finding that
HIV-1 gp120 interaction with CD4 alters the activity of
transcriptional regulators and cytokine transcription [7] is
present as nine entries in the HHPID, when this activity
can be explained through a direct interaction at the cell
surface, causing downstream effects in the T cell receptor
signaling pathways. However, by simply taking direct
interactions from this database to determine host cell
perturbation, important regulatory effects may not be
considered or alternatively, perhaps falsely extrapolated.
Due to these reasons, while the HHPID is a unique, detailed
source of individual PPI interactions that represents a large
proportion of the knowledge in the published literature, it does not
immediately provide a logical and functional map of HIV-1-host
interaction.
Recently, three high-throughput HIV-human protein interac-
tion data sets have been published that are the result of individual
genome-scale siRNA gene knockdown screens [8–10]. These
studies each identify over 200 host-cellular factors that are
necessary for HIV-1 replication, termed ‘HIV-dependency factors’
(HDFs) [8]. A thorough meta-analysis of HDFs has been
performed by Bushman et al. [11]. Though the pairwise
intersection of genes between the three sets of HDFs is statistically
significant in all cases [11], the number of genes confirmed by
more than one study is only 34 and just three genes are present in
all sets. This seemingly small overlap is largely thought to be due to
differences in experimental procedure, including cell-type, choice
of time points analyzed and choice of filtering thresholds [1,9–11].
Despite the apparent small overlap between HDF sets, Bushman
et al. demonstrate that certain cellular subsystems are mutually
identified, such as DNA repair and nuclear transport associated
proteins. This indicates the validity of the screen results and the
value that can be gained by combining these data to identify
essential host-cellular functions required by HIV-1 for replication.
In addition, their study shows that intersections between HHPID
data and the HDF sets, while significant are quite small at 39 [8],
54 [9] and 39 [10] genes. However, while the work of Bushman
et al. successfully consolidates information between HDF sets and
validates these sets against the HHPID, the underlying differences
between the HHPID and siRNA screen results have not been
explored in detail. In particular, cellular subsystems prevalent in
the HHPID, but not present among HDFs, have not been
identified.
Our previous visualisations of the HIV-human PPI network
show that there are noticeable clusters of host proteins that take
part in multiple interactions with the same set of HIV-1 proteins
[4,12]. These groups possibly represent multiple interactions with
biologically related proteins, e.g., from functional pathways or
protein complexes. In addition, highly connected subnetworks of
host proteins, where some proteins are involved in multiple HIV-
human interactions, have also been identified using a combination
of human-human PPI data and HIV-human interaction data
[9,11]. These subnetworks represent specific biological activities
including the ubiquitin-proteasome pathway, transcription, nucleic
acid binding and nuclear import; all thought to be important in
facilitating the early stages of HIV-1 infection [9]. However, in all
of these studies, different types of HIV-1-host interaction are not
taken into consideration in the clustering method, despite the
potential for interactions to be quite dissimilar. For example,
subnetwork PPIs may include direct binding interactions, indirect
regulatory interactions and those with opposing actions, e.g.,
inhibition and activation, such that no systematic outcome is
identifiable.
In this work, we explicitly utilise host-virus interactions and
interaction types, as provided in the HHPID, to identify significant
patterns of viral perturbation of the host cell. This permits us to
gain meaningful insights into HIV-1 infection. Specifically, using a
biclustering approach, we define sets of host proteins that take part
in a common set, or ‘profile’, of HIV-1 interactions. Using a
distance method to cluster these units, we identify higher-level
groupings. We show that these higher-level groups of proteins map
to specific biological subsystems in the host cell. By considering
patterns of interaction with host cell proteins, evidence within
primary literature and by assessment of support from global
siRNA screens, we are able to infer the biological importance of
these subsystems in terms of HIV-1 replication, host cell
perturbation and regulation of the immune response. Thus, our
work extracts a coherent functional map of core HIV-1-host
interactions from the HHPID and consolidates findings from the
major HIV-1-host PPI data sets.
Results/Discussion
Patterns of HIV-1-host interaction
We retrieved 1434 human proteins and 3939 distinct HIV-1-
human PPIs from the HHPID. In order to precisely reflect
findings from HHPID source papers and to maximise our
capability to discern patterns within the data, all 19 HIV-1
proteins were used in our analysis. Not surprisingly, types of HIV-
human PPI are not uniformly distributed among HIV-1 proteins,
due to the different molecular functions of these proteins. We
found that 18 from 19 HIV-1 proteins (all except Pol) take part in
one or more interaction type with a frequency greater than
expected by random chance (pv0:001). These over-represented
interactions include 47 of the 68 interaction types given in the
HHPID and 60 distinct interaction-type/HIV-1 protein combi-
Author Summary
HIV-1 is responsible for millions of deaths every year by
causing acquired immunodeficiency syndrome (AIDS).
Therefore, research is ongoing in order to better under-
stand and counter HIV-1 infection. Like any virus, HIV-1
must enter host cells and use cellular machinery to
replicate. To do this, proteins of the virus interact with
the proteins of the cell. Many studies have identified
specific virus-host protein interactions and a database
known as the HIV-1, Human Protein Interaction Database
was created for reference and further study to understand
HIV-1 infection. In this work, we use the HHPID to find
significant patterns of HIV-host interaction in order to
identify core processes that are active during infection and
also to highlight host cellular subsystems that are affected
by HIV-1. We discuss the importance of these subsystems
and associated interactions—in particular, whether the
host proteins are supported by other recent data sets that
were designed to find host factors essential for HIV-1
replication. We highlight mechanisms from essential steps
in the viral life cycle as well as perturbations of the host
immune response. Our work provides an accessible insight
into HIV-1 infection.
The Core Host-Subsystems Used by HIV-1
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is a protease required in the HIV-1 life cycle to cleave viral
polyproteins [13]. In addition, retropepsin cleaves proteins of the
host cell [14–17], hence, retropepsin is responsible for all but one
of 61 distinct ‘cleaves’ interactions. (ii) The HIV-1 accessory
protein Nef can impact expression levels of multiple genes during
the viral life cycle including proteases, cell-surface proteins,
kinases, cyclins and transcription factors [18,19]. Hence, Nef is
responsible for a greater proportion of both upregulatory and
downregulatory interactions than would be expected by random
chance (p~2:5e{5). (iii) HIV-1 Tat is a transcriptional regulator
that does not function alone [20], rather Tat works by recruiting
other regulators [21,22] and hence takes part in a greater
proportion of interactions with type ‘recruits’ (p~1:1e{7) and
‘binds’ (p~1:1e{4). This over-representation analysis indicates
that simple patterns of interaction (linking certain HIV-1 proteins
to certain interaction types) are present in the HIV-1-host
interaction network.
To computationally identify more complex patterns of virus-
host interaction, we investigated human proteins that take part in
more than one distinct PPI with HIV-1 proteins. An outline of our
method for analysis of HIV-1 interaction is given in figure 1. As a
first step towards identifying key host functions known to be
involved in HIV infection, we use biclustering to define groups of
human proteins that share a common set (or ‘profile’) of HIV-1
interactions, in terms of HIV-1 protein interactant and interaction
type (figure 2). The binary interaction matrix contained 1434
rows, 1292 columns and 3939 positive values, corresponding to
human proteins, all types of HIV-1 interaction and all HIV-1-
human PPIs, respectively. Biclustering of this matrix yielded 1306
biclusters that include a minimum of two human proteins, each
with a minimum of two distinct HIV-1 interactions. We identified
279 from 1306 biclusters that were statistically significant
(pv0:001) by Monte Carlo simulation. A table with details of all
significant biclusters, including their constituent human proteins,
HIV-1 proteins, interaction types and links to the HHPID are
given in supplementary Table S1.
These biclusters define significant profiles of HIV-1 interaction
and a corresponding set of human proteins, or termed differently,
significant sets of human proteins that undergo similar perturba-
tions during HIV-1 infection. Included in the significant biclusters
were 246 human proteins, 18 proteins of HIV-1 (all except p6) and
1665 distinct HIV-1-human PPIs. According to the classes of
bicluster, defined according to relationships between interactions,
we found 122 independent, 137 mixed, 11 parental, 9 family and
no sibling significant biclusters. Both independent and mixed
biclusters, according to our interactions hierarchy (see supple-
mentary Text S1), include a minimum of two unrelated types of
PPI between every HIV-human protein pair. This indicates that
our study of multiple interactions is informative and potentially
valuable, as in w90% of cases, bicluster interaction profiles
include two or more types of interaction that provide distinct,
additional information regarding the perturbation of the human
proteins.
We expected significant biclusters to be enriched for well-
studied, high-confidence interactions, since they are likely to
correspond to identifiable units of biological function and well
established modules that have been investigated more thoroughly
than smaller, insignificant biclusters or singleton interactions. This
hypothesis was tested by counting publications that support the
interactions, as given in the HHPID. Whilst we do not regard
publication count to be an ideal measure, it is a reasonable and
accessible estimate for confidence in a given PPI. We found that
interactions within significant biclusters had a mean of 2.94
supporting publications, while other interactions with human
proteins that could potentially be in biclusters (these take part in at
least two distinct interactions with HIV-1 and are referred to as
‘potential bicluster proteins’ or PBPs) have a mean of 2.46 and
interactions with all non-biclustered interactions had a mean of
2.29. Mann-Whitney U tests performed on the publication count
distributions of biclustered interactions versus PBP interactions
and biclustered interactions versus all non-biclustered interactions,
demonstrated that the distributions were significantly different
(pv0:001, in both cases). While we do not suggest that
interactions outside of these biclusters are false positives and that
all interactions within these biclusters are of elevated importance,
this finding does indicate that the overall patterns of interaction
defined by significant biclusters that we discuss in this work, are
likely to be biologically valid.
HIV-1 interaction profiles define biologically cohesive
sets of human proteins
To validate the biological significance of host protein sets and
their associated interaction profiles (as defined by biclusters), we
determined whether human proteins from within significant
biclusters were more biologically similar to one another than
expected by chance, assessed according to three measures: PPI
network clustering to infer a greater then expected frequency of
PPIs; semantic similarity in terms of shared Gene Ontology (GO)
annotation [23] to infer shared biological roles; and sequence
similarity to infer homologous relationships, as functional modules,
such as protein complexes, are known to have a tendency to
include paralogs [24]. These similarities were determined by
comparing the host protein groupings to randomly selected sets
sampled from 692 PBPs. Results for these measures are discussed
below, followed by a summary of the three measures. In addition,
detailed results, per significant bicluster, are given in supplemen-
tary Table S2.
PPI network clustering
Integrating human proteins from significant biclusters into a
human PPI network, we identified 38 biclusters where the proteins
share a greater number of interactions, 24 where the proteins form
a bigger largest connected component (LCC) and 38 where the
proteins have a smaller average shortest path length than would be
expected by random chance (pv0:05). A total of 66 biclusters
appear in the union of these three measures and figure 3A gives
details of their intersection.
These results show that HIV-1 has a tendency to interact in
similar patterns with host proteins that share interactions with one
another, indicating the presence of multiple HIV-1 interactions
with host protein complexes or other closely associated host
network modules. There are several prominent examples of
complexed proteins that constitute all of the host proteins defined
by significant interaction patterns including: class II major
histocompatibility complex (MHC), general transcription factor
IIH (TFIIH), casein kinase II, adaptor-related protein complex 1,
protein phosphatase 2A, N-methyl-D-aspartate receptor, micro-
tubule subunits and RNA polymerase II (RNAP II). In some cases
HIV-1 interaction patterns with these complexes become
significant due to the number of subunits that undergo a set of
interactions. For example, one significant combination of
interactions acts upon nine subunits of the RNAP II complex,
hence, these proteins have more shared edges than would be
expected at random. In this case, the interactions are general,
pertaining to the complex rather than being subunit specific, e.g.,
upregulation of RNAP II due to HIV-1 gp120 [25]. However, we
also identify peptides from complexes that undergo subunit-
The Core Host-Subsystems Used by HIV-1
PLoS Computational Biology | www.ploscompbiol.org 3 July 2010 | Volume 6 | Issue 7 | e1000863specific interactions with the proteins of HIV-1. For example, one
such bicluster involves HIV-1 Tat binding and regulation of
specific polypeptides of TFIIH [1,4,5]. Yet, there are five other
transcription-related host proteins within this interaction combi-
nation. In this case Tat interactions affect a functional module in
the human PPI network (involving 18 interactions among the nine
proteins, forming a single connected component) that corresponds
to proteins of transcriptional regulation.
Figure 1. Summary of methodology. This diagram provides an outline of our method, steps are numbered according to the order in which they
are discussed in the main text.
doi:10.1371/journal.pcbi.1000863.g001
The Core Host-Subsystems Used by HIV-1
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Biclustered proteins are more similar in terms of their GO
annotation than would be expected by random chance in all
ontologies: molecular function, cellular component and biological
function (pv v0:001). Semantic distance distributions for human
protein pairs from within biclusters and all other PBP pairings, for
each ontology are shown in figure 4, graphs A to C. We identified
75 significant biclusters that include human proteins that are
significantly similar in their GO annotation, for at least one
ontology, from a possible 204 significant biclusters that include two
or more genes with GO annotation (pv0:05). Details of the
intersection between results for each ontology are given in
figure 3B.
These results show that HIV-1 interacts in a similar pattern with
proteins that have similar GO annotation. We are able to observe
these similarities in all GO ontologies. For example, protein kinase
C (PKC) isoforms that comprise all human proteins of one
bicluster are annotated with the molecular function ‘protein kinase
C activity’. Some cellular component GO terms refer directly to
protein complexes. Certain biclusters involving complexes are
therefore linked via common annotation, such as one that
corresponds to RNAP II, annotated with GO term ‘RNA
polymerase complex’. Interestingly, we are also able to observe
HIV-1 interaction patterns that act upon specific biological
processes including the immune response, protein kinase cascades,
lipid modification, transcription, nuclear import and microtubule-
based movement. The combinations of interaction that affect these
processes can highlight the molecular methods through which
HIV-1 infection perturbs cellular processes.
Sequence similarity
Human protein pairs within significant biclusters are more
similar in their protein sequence than would be expected by
random chance (pv v0:001). Distributions for sequence identity
between human protein pairs from within biclusters compared to
random pairings are shown in figure 4D. We identified 101
significant biclusters where the human proteins were more similar
in their sequences than would be expected by random chance
(pv0:05). No biclusters were significantly less similar in their
human protein sequences than would be expected.
We identify 58 biclusters for which a group of homologous
proteins comprises more than half of the members of that cluster.
We defined these homologous relationships by performing single
linkage clustering on proteins, where proteins are linked if they
share w40% sequence identity. This cutoff was chosen as previous
work has demonstrated that 40% sequence identity can accurately
infer homology without the inclusion of an unacceptable
proportion of false positives [26]. We found that significant
biclusters with greater than expected sequence similarity among
their host proteins (pv0:05) were also more likely to have at least
one direct physical HIV-1 PPI (p~7:81|10{5) and the mean
average proportion of direct HIV-1 PPIs among this group of
biclusters was 25.5%, as opposed to 11.8% for all other significant
biclusters.
These results show that paralogous groups of host proteins have
a tendency to be subject to the same combinations of regulatory
and physical HIV-1 interaction. Regulatory effects of HIV-1
interaction may be maintained across these groups, perhaps
through stimulation of specific pathways. For example, isoforms of
PKC, a kinase found to act in many signaling cascades [27], are
the only host proteins among three particular significant biclusters.
HIV-1 gp120 has been shown to upregulate multiple isozymes of
PKC, possibly through classical signal transduction pathways [28],
induced by binding to cell-surface receptors such as CCR5 [29].
However, the prominence of direct physical interactions among
these homologous sets of proteins implies that there are conserved
binding domains on members of closely related homologous
groups, to which a HIV-1 protein can bind. For example, HIV-1
Vpr is designated in the HHPID to bind both importin-a 1 and 2
isoforms; as these proteins are w40% similar in a pairwise
alignment, it seems likely that Vpr would bind a particular
conserved domain of these proteins. However, various members of
protein families can exert distinct phenotypic responses. In the
case of PKC isoforms, cellular localisation and activation input can
be controlled by the specific domain structure [27]. Different
members of protein families may also exert distinct phenotypic
responses due to their cellular background, caused by differential
expression, but also by activating downstream targets to different
quantitative levels, as shown for receptor tyrosine kinases [30,31].
Therefore, to precisely determine HIV-1 perturbation, it remains
important to distinguish what protein isoforms and family
members are dysregulated and in what cell type this activity
occurs.
TAT: INHIBITS
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NUCLEOCAPSID: BINDS
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NP_000005.2 1000100
0110100
1000001
0001000
0110110
0100000
0000001
NP_001091.1
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Figure 2. An example portion of the interactions matrix used in
biclustering. (A) Shows an example portion of the interactions matrix.
‘1’ represents the presence of a given interaction, while ‘0’ the absence of
that interaction, between a human protein interactant (shown left) and
an HIV protein; the interaction having a given outcome (shown above).
The entire matrix was biclustered to identify sets of host proteins that
undergo the same set of HIV-1 interactions. (B) Shows an example
bicluster that would be found in the portion of matrix given in (A).
doi:10.1371/journal.pcbi.1000863.g002
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A summary of results from the three measures of biological
relationship between proteins, in terms of the number of
significant biclusters, is given in figure 3C. We find 151 from
279 biclusters are significant by one or more measure. Therefore,
these measures are not mutually exclusive. In fact, in some cases,
overlap may be due to a single biological phenomenon, e.g.,
homologous proteins that form a single complex are likely to be
involved in the same biological process, in the same cellular
compartment, possibly with the same molecular functions. For
example, transcriptional regulators CREB binding protein (CBP),
E1A binding protein (p300) and cyclin T1 are all found in one
such bicluster whose interaction profile includes binding of these
proteins to HIV-1 Tat and Vpr. CBP and p300 are w60%
identical in local pairwise alignment, however, rather than binding
Tat individually, they form a dimer (known as PCAF) [32]. Cyclin
T1 shares only a low level of sequence similarity (v30% identity in
local pairwise alignment) to the other two proteins. Therefore
among these three host proteins there is a known PPI, a
homologous relationship and all are transcriptional regulators
involved with Tat mediated transactivation of the HIV-1 LTR
[33] and hence have some common GO annotation. Furthermore,
gene annotations including GO and PPIs may be attributed based
on homology to genes with experimentally validated actions, for
example, GO evidence code ‘ISA’, stands for ‘inferred from
sequence alignment’ and is one of six codes describing computa-
tional assignment of annotation. Hence, the measures used here
are linked. Some annotation is electronically inferred without any
manual curation and as a result is error-prone [34]. In addition,
false positive annotations can be propagated electronically [35,36].
However, we chose not to select manual annotation alone as the
potential reduction in false-positives is offset by an increase in
false-negatives. For example, more than half GO annotations of
human genes have the evidence code ‘IEA’ meaning ‘inferred
from electronic annotation’ (see http://www.geneontology.org/
GO.current.annotations.shtml).
We do not identify significant biological relationships among
128 biclusters. These biclusters include significantly fewer human
proteins on average ( x x~2:32) than the 151 biologically cohesive
biclusters ( x x~4:14)( p~2:2|10{16, Mann-Whitney U test).
Therefore, power to detect statistically significant biological
relationships (despite their possible existence) among human
proteins of these biclusters, is diminished, especially where
annotation is lacking. For example, two subunits of the casein
kinase II complex (alpha 1 and beta) are found in one such
bicluster. At the time of performing this work neither of these
subunits were GO annotated, they are not more than 30% similar
by local pairwise alignment and though they interact, this is
insufficient to be called statistically significant. However, in some
cases, no biological relationship can be discerned, even on
inspection. Yet, of these 128 biclusters, 125 include fewer than
three human proteins and none include more than four. This
indicates that our combination of methods for detecting
biologically cohesive human protein sets via biclustering, and
detecting biological relationships among these biclusters, performs
well in terms of quality, where the number of human proteins is
four or greater.
Figure 3. Venn diagrams showing biological cohesiveness
among proteins within significant biclusters, using three
measures. Counts refer to the number of biclusters that include
human proteins that are significantly biologically related (pv0:05) from
a possible 279. (A) Displays three network clustering measures: shared
edge count, average shortest path and largest connected component.
(B) Displays semantic similarity in terms of the three GO ontologies. (C)
Displays the overlap of all three measures of biological cohesiveness:
semantic similarity, network clustering and sequence similarity.
doi:10.1371/journal.pcbi.1000863.g003
The Core Host-Subsystems Used by HIV-1
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combinations
Owing to the specific biclustering method that we used for
defining significant profiles of HIV-1-host interaction, multiple
biclusters arise from slight differences between protein sets that are
essentially similar in their interaction profile. This is partly due to
differently annotated interactions, interactions that are not
maintained across a group of otherwise similarly interacting
proteins, or even to missing interactions that have not been
experimentally proven or are missing from the HHPID, i.e., false
negatives. For example, in the case of two biclusters that include
homologs of Akt (also known as protein kinase B), one pertains to
homologs 1 and 2, the other to homologs 1, 2 and 3. These two
biclusters occur because homologs 1,2 and 3 have been shown to
share similar interactions with HIV-1 gp120 and Vpr. However,
while homologs 1,2 and 3 are activated by Tat, only homologs 1
and 2 are shown to be upregulated by Tat in the HHPID [1,4,5].
Therefore, by combining biclusters according to shared informa-
tion, we can form an overview of HIV-1 interactions with a given
set of host proteins.
Higher-level relationships between biclusters were identified
using a distance measure based upon overlap between biclusters.
Using the resulting pairwise distances a tree was constructed using
the neighbor joining method [37] (see figure 5). This tree has been
partitioned into sections, representing 37 biological subsystems
within the host cell that are named according to over-represented
GO terms, or after a specific protein (see materials and methods
for more detail). In the tree representation we can observe
subsystems that undergo a complex set of interactions during HIV-
1 infection. These have a large number of terminal branches,
representing many distinct but related HIV-host interaction
combinations, where a single and clear pattern of interaction
can not be simply defined, or does not exist, e.g., the cytokine activity
subsystem. Conversely, the v-akt subsystem is relatively well
defined including just two closely related HIV-host interaction
combinations.
The identified subsystems and their associated patterns of
interaction take place at a variety of levels within the host cell,
including interactions at the cell surface and with specific
biological components such as the proteasome. Cellular processes
and pathways, including intracellular signaling cascades, apoptosis
pathways and stimulation of the immune response, better describe
other subsystems. In addition, some subsystems can be directly
mapped to specific steps in the viral life cycle, including viral
budding and transport of viral RNA across the nuclear membrane.
Supplementary Table S3 gives details of each subsystem, including
the number of biclusters, host and virus proteins. Supplementary
Table S1 links individual biclusters and interactions to these
subsystems.
Among these subsystems, there appears to be a central pathway
of T cell signaling interactions that are perturbed by the proteins of
HIV-1 at multiple levels in the cell. This pathway begins with
Figure 4. Comparison of protein pairs within significant
biclusters to other protein pairs. Panels A, B and C show the
semantic distance distributions for the three GO ontologies: biological
process, cellular component and molecular function, respectively, for (i)
human protein pairs from significant biclusters (shown in grey) and (ii)
all other human protein pairs from PBPs (shown in black). Panel D
shows the pairwise sequence similarity distributions for (i) and (ii). These
charts show that human proteins from within significant biclusters are
more similar in their GO annotation and sequence than other protein
pairs (pv0:001 in a Mann-Whitney U test, in all cases).
doi:10.1371/journal.pcbi.1000863.g004
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example, HIV-1 gp120 binding to CD4 prevents typical host-host
cell-surface interactions, such as MHC-class II response to antigen
binding [38], CD28-mediated co-signaling [39], and CD3-induced
leukocyte-specific protein tyrosine kinase (Lck) and phospholipase
C activation [40,41]. In addition, HIV-1 Nef downregulates CD4,
CXCR4, CCR5, CD28, CD71, CD80, CD86 and MHC class I
molecules via endocytosis [42–47].
Figure 5. Tree showing the relationship between significant biclusters and higher-level host subsystem groupings. Individual
biclusters are represented by terminal branches. Relationships are derived using a distance measure based on the proportion of shared interactions
between significant biclusters and the tree was drawn using the neighbor joining method. The tree is divided into sections that show the higher-level
host subsystems, largely derived using the tree structure. Subsystems of w2 biclusters are colour coded (see key). Biclusters not labelled are those
that have been placed in a biologically related group not adjacent on the tree.
doi:10.1371/journal.pcbi.1000863.g005
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locations. For example, in the MAP kinase subsystem we find Lck, a
component of TCR signaling and an activator of other cell signal
transduction proteins including the ERK family of MAP kinases
[48–51], is activated through gp120 binding to CD4 [52–54].
HIV-1 Nef also plays a role in the activation of the classical MAP
kinase pathway via binding and activation of Lck [55,56] and also
Vav, causing downstream activation of JNK MAP kinases [57,58].
Stimulation of these signaling cascades by proteins of HIV-1
influences a variety of cellular responses that include activation of
transcription factors, for example [54,59]. The nuclear factor
subsystem includes nuclear factors of activated T cells (NFATs),
transcriptional regulators that induce production of cytokines
[60,61]. We observe that NFATs are enhanced or activated at
several levels within the host cell, by HIV-1 proteins Vpr, Tat, Nef
and gp120, causing dysregulation of cytokine production [62–67].
Altered cytokine signals will then be received by cell-surface
receptors, thus, completing a cycle of viral perturbation.
To summarise the interactions between cytokines and proteins
of HIV-1, we produced networks of both upregulation and
downregulation, taking interactions from the cytokine activity
subsystem, including interactions that are supported by more
than one publication, as given in the HHPID (see figure 6). These
networks illustrate the complexity of cytokine dysregulation by
HIV-1. From 53 distinct HIV-protein, host-protein pairings in
these networks, 30 pairs involve only cytokine upregulation, 12
pairs involve only cytokine downregulation and 11 pairs involve
both cytokine upregulation and downregulation, in response to the
HIV-1 protein interactions. Cytokine dysregulation is likely to
have major pathogenic effects on the host system. For example, an
increase in plasma levels of multiple cytokines during acute HIV-1
infection, coined an ‘early cytokine storm’, is associated with peak
viral loads and immunopathological consequences [68].
In these network visualisations there are distinguishable patterns
of cytokine regulation by HIV-1, such as, the largely stimulatory
effects of gp120, Tat and Nef; upregulation of TNF-alpha and
Interleukins 1 and 6; the repressive action of Vpr and gp160; and
downregulation of interleukin 2 and interferon-c. However, the
overall picture of cytokine regulation during HIV-1 infection
remains unclear. Future cytokine-wide studies of HIV-1 infected
cells, ideally representing multiple different stages of infection and
possibly even a variety of HIV-1 strains, coupled with an accurate
model of cytokine action on the host system could improve our
understanding of HIV-1 pathogenesis and potential intervention
targets, particularly if key HIV-host interactions are identified.
To present distilled views of the HHPID and provide an
interpretable network of HIV-1-host interaction, two HIV-1-host
PPI networks were constructed. Both networks include 37 nodes
that represent the characterised subsystems. The first network,
shown in figure 7, has 18 nodes that represent the proteins of HIV-
1. The second network, shown in figure 8 has 49 nodes that
represent interaction types. The edges in these networks represent
HIV-1-host interactions that contribute to significant biclusters,
the width of each edge is proportional to the number of distinct
interactions that are represented. Due to the condensed host
functions and filtering out of patterns of interaction that are not
statistically significant we can observe recognisable patterns of
interaction in these networks. For example, (i) the relationship
between HIV-1 Tat and regulators of transcription that are
stimulated, activated and recruited by HIV-1 in the process of
viral transcription. (ii) The multiple sources of perturbation of T
cell activation from HIV-1 Nef, Tat and the envelope proteins.
And, (iii) the large number of regulatory interactions between
proteins of HIV-1 and host cytokines.
Support for host subsystem functions among global
siRNA data sets
To assess support for the 37 host subsystems from HDFs
identified by global siRNA screens [8–10], we defined subsystem
annotations that consist either of defining over represented GO
terms or a regular expression that encapsulates a common protein
Figure 6. Cytokine regulation networks. These networks represent the pattern of cytokine regulation in the cytokine-activity host subsystem
that were defined through identifying significant patterns of HIV-host interaction. Edges represent PPIs. Edge width is proportional to the number of
PPIs being represented. For clarity, we only show PPIs that are reported more than once in the HHPID. These networks show that cytokine
dysregulation due to HIV-1 infection is wide reaching and complex, affecting many host cytokines, both via upregulation (left) and downregulation
(right).
doi:10.1371/journal.pcbi.1000863.g006
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S3. We found that 10 from 37 subsystem annotations also define
statistically over-represented groups among either all HDFs
combined or a single HDF study (pv0:05). We find that 21 from
37 subsystems include at least one protein that is also present
among HDFs and only in three cases is the intersection statistically
significant (see supplementary Table S3 for more details).
Cellular subsystems supported by HDF sets
The 10 subsystems that are supported by HDFs are: proteasome
core complex, regulation of apoptosis, mRNA transport, endosome, RNA
polymerase activity, peptidase activity, regulation of transcription, ubiquitin,
cAMP-dependent protein kinase complex and v-akt.
Subunits of the proteasome core complex are present among two
of the three siRNA screens [8,9]. A meta-analysis of these HDF sets
that incorporatesdatafrom the HHPID,showed that the proteasome
is an important cellular component for HIV-1 replication [11]. The
role of the proteasome in HIV-1 replication remains unclear.
However, the interactions that we highlight between HIV-1 Tat and
the beta-8 and beta-10 subunits may be important for determining
proteasome composition, towards formation of the immunoprotea-
some, a change that may cause increased presentation of subdom-
inant epitopes [69,70].
Apoptosis is widely accepted as a mechanism for T cell depletion
in HIV-1 infected individuals [71]. By reviewing relevant literature,
we find that several subsystems may have a role in controlling
apoptosisincluding:regulationofapoptosis,glutamatereceptoractivity,v-akt,
lactate dehydrogenase activity and peptidase activity. HDFs found by one
siRNA screen [10] are enriched for regulators of apoptosis.
However, in our results, we only identify one HDF, Cytochrome
C thatis GOannotated asa regulatorofapoptosis inadditionto Akt
and components of the glutamate receptor. We speculate that
Figure 7. HIV-1-host interaction patterns, by HIV-1 protein. This network illustrates core patterns of HIV-host interaction. The human host is
depicted as a series of cellular subsystems, represented by orange circular nodes, where the diameter of the node is proportional to the number of
host proteins within that subsystem. HIV-1 is depicted by the viral proteome (blue triangles). Interactions between HIV-1 proteins and host
subsystems are represented by edges, where the edge width is proportional to the number of interactions. For clarity, only those interactions that are
shared by over half of the host proteins in a subsystem are shown. *Indicates a host subsystem whose subsystem annotation corresponds to a
statistically significant group among HDFs (pv0:05). { Indicates a statistically significant intersection between the subsystem proteins and HDF set
(pv0:05).
doi:10.1371/journal.pcbi.1000863.g007
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HIV-1 infection, in order to maintain a viral reservoir in the host
[72]. In this case, HDFs may not include the pro-apoptotic host
proteins that we observe in these interaction patterns. In addition,
proteins such as Akt and Cytochrome C have roles outside of
apoptosis[73,74].Therefore,thenecessity forsuchproteinsinHIV-
1 replication is not necessarily apoptosis related. However, we
identify subsystems from the HHPID that can be linked to positive
regulation apoptosis, such as regulation of apoptosis that includes the
activation of pro-apoptotic caspases by multiple HIV-1 proteins.
The intensity of research to elucidate key interactions responsible
for T cell loss, via apoptosis, in HIV-1 infected individuals is
demonstrated by the prominence of pro-apoptotic HIV-host
interactions in our results. However, we suggest that a greater
range of interactions between proteins of HIV-1 and host regulators
of apoptosis need to be investigated, particularly involving those
host factors that are present among HDFs but not identified in our
results.
Interactions in the mRNA transport subsystem all involve HIV-1
Rev. One of the roles of Rev is to facilitate export of HIV-1 RNA
from the nucleus to the cytoplasm. A nuclear export signal present
in the Rev protein binds to exportin 1, while an argenine-rich
domain (ARD) in Rev binds to a Rev-response-element (RRE)
present in viral RNA. To undergo nuclear export, an exportin-
Rev-RNA complex docks at a nuclear pore complex (NPC), an
interaction mediated by nucleoporins [75]. In the mRNA transport
subsystem we find interactions that are specific to this process
including but not limited to: binding [76] and recruitment [77] of
Figure 8. HIV-1-host interaction patterns, by interaction type. This network illustrates core patterns of HIV-host interaction. The human host
is depicted as a series of cellular subsystems, represented by orange circular nodes, where the diameter of the node is proportional to the number of
host proteins within that subsystem. The action that HIV-1 has on these subsystems is depicted by a series of interaction outcomes (blue diamonds).
Interactions between HIV-1 and host subsystems are represented by edges where the edge width is proportional to the number of interactions. The
directionality of the interaction is implicit in the description of the interaction outcome. For example, the edge linking the MHC protein complex
node and the ‘upregulates’ node represents ‘HIV-1 upregulates the MHC protein complex’, whereas the edge linking the cytokine activity node and
the ‘activated by’ node represents ‘HIV-1 is activated by cytokine activity’. For clarity, only those interactions that are shared by over half of the host
proteins in a subsystem are shown. *Indicates a host subsystem whose subsystem annotation corresponds to a statistically significant group among
HDFs (pv0:05). { Indicates a statistically significant intersection between the subsystem proteins and HDF set (pv0:05).
doi:10.1371/journal.pcbi.1000863.g008
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nucleoporin proteins [78], including Rev mediated recruitment of
these host factors to the nucleus [79]. We find that there are a
statistically significant proportion of host factors involved in
mRNA transport in two of the three global siRNA studies
(references [8,9]). Furthermore, all host genes that make up this
subsystem (a total of five) are found among HDFs (p~0:00014).
Down-modulation of these host factors, either in small-scale
experiments or by global siRNA screen, apparently inhibits the
interactions described in this subsystem, thereby preventing Rev-
mediated RNA nuclear export and successful viral replication.
We observe two other subsystems that appear to have a role in
transport of HIV-1 material into the nucleus, nuclear import and heat
shock protein 70kDa. Briefly, the nuclear-import subsystem involves a
variety of interactions with members of the karyopherin family and
heat shock 70kDa chaperone protein (Hsp70). Karyopherins bind
sequence motifs called nuclear localisation signals (NLS) of proteins,
causing the protein to be directed into the nucleus [80]. We observe
that HIV-1 Integrase, Matrix, Tat and Rev proteins are bound or
imported into the nucleus by members of the karyopherin family. In
the case of Integrase and Matrix, these interactions may relate to
karyopherin mediated nuclear import of HIV-1 preintegration
complexes (viral ds-RNA and associated proteins known as PICs)
[81], a mechanism that may also involve HIV-1 Vpr. Several
isoforms of the heat shock 70kDa chaperone protein (Hsp70)
promote PIC import, possibly by stimulating interaction between
PIC complexes and karyopherin [82]. These two nuclear import
subsystems include support from siRNA screens. One of the three
studies identified karyopherin-b [9] and two studies [8,9] identified
transportin 3 (TNPO3), a less definitively characterised member of
the importin-b/karyopherin-b superfamily, as HDFs. More recent-
ly, TNPO3 has been reconfirmed by yeast-two-hybrid pull-down as
a binding partner of Integrase, to be an early-stage HDF in the viral
life cycle by siRNA screen and a clear promoter of HIV-1 PIC
import [83], though subsequent work has shown that HIV-1
requirement for TNPO3 maps to interaction with Capsid rather
than the Integrase protein [84]. Therefore, current experimental
data indicates that TNPO3 is essential for PIC import, whereas the
roleforkaryopherin-b inthisprocess remainsunclear. Requirement
for karyopherin-b observed in [9] could be indirect, perhaps for
transport of another HDF.
Budding, the release of the viral particle from the host cell
plasma membrane, is an essential step in the HIV-1 life cycle. We
identify two subsystems that have a role in budding: protein
localisation and ubiquitin. Both of these groups include interactions
involving HIV-1 p6, a region of the Gag protein that contains a
late domain (L-domain). L-domains recruit host-cellular factors
required by HIV-1 for budding. Our results indicate that p6 (along
with other viral proteins) is ubiquitinated at the L-domain by three
forms of ubiquitin (B, C and D). The p6 L-domain also interacts
with subunits of the ESCRT-I complex, possibly via direct
interaction with AIP-1/ALIX. These interactions, though not fully
understood, have been shown to be important for HIV-1 budding
[85] and are found in our results. These host factors are not
identified among HDFs. However, HDFs include both ubiquitin-
conjugating enzymes and ubiquitin-protein ligases. Therefore, it
appears that ubiquitination plays an important role in HIV-1
replication that can be linked to viral budding.
In our results we define four subsystems where the host proteins
and interactions contribute to HIV-1 provirus chromosomal
integration and HIV-1 RNA transcription, namely, regulation of
transcription, DNA helicase, RNA polymerase activity and DNA integration.
The largest of these groups is regulation of transcription that includes
many direct binding and co-stimulatory interactions between HIV-
1 proteins Tat and Vpr, and host transcriptional regulators
including: cyclin-dependent kinase 9 and cyclin T1 that form the
Positive Transcription Elongation Factor b complex, general
transcription factors TFIIF and TFIIH; NFkB; TATA box binding
protein; cyclin-dependent kinase 9; CREB binding protein; p300;
and p300/CBP-associated factor [86,87]. Both the size of the
intersection between this subsystem and HDFs and the proportion
of genes annotated by GO as regulators of transcription is
statistically greater than expected by random chance (p~0:0034
and p~0:0038, respectively). Transcriptional regulators we identify
that are also among HDFs include cyclin t1, NFkB, p300, TFIIF
and TFIIH, as well as subunits of the RNA-polymerase II complex,
as found in the RNA polymerase activity subsystem. Therefore, these
host factors appear to form an essential functional module, with a
clear pattern of interaction required for HIV-1 replication.
The DNA integration subsystem includes interactions between
HIV-1 Integrase and three host proteins: LEDGF, a transcrip-
tional activator; hSNF5, a subunit of the SWI/SNF ATP-
dependent chromatin-remodeling complex; and embryonic ecto-
derm development (EED) protein. Integrase is involved in binding
interactions with both LEDGF and hSNF5. LEDGF binds to
Integrase and tethers it to host chromatin, an interaction identified
as essential to HIV-1 infectivity [88,89]. However, LEDGF is not
found among HDFs, perhaps because this host factor is only
required at a very low level, thus, eluding identification by siRNA
knockdown screening [89]. This highlights the possibility that
more host proteins shown to be essential for HIV-1 replication in
specific, small-scale experiments may not be found among HDFs.
By cross referencing host proteins involved in significant
patterns of interaction from the HHPID we have found support
among siRNA screen data for host subsystems that can be linked
to viral transcription, viral budding, PIC integration, transcription
of viral RNA, changes to proteasome composition, export of viral
RNA from the nucleus and regulation of apoptosis. However, of
these, all but regulation of apoptosis and changes to proteasome
composition might be considered an essential molecular mecha-
nism for HIV-1 replication. Moreover, from our results it is
unclear whether pro-apoptotic interactions are essential.
Lack of support for T cell signaling and immune-related
subsystems among HDFs
The remaining subsystems are not well supported by data from
siRNA screens, in particular, those pertaining to cytokine
dysregulation caused by HIV-1 infection. We do not find that
HDFs are enriched for components of the TCR or for proteins
involved in T cell activation. However, we do find that CD4 and
CXCR4 have both been identified by our interaction patterns and
by two siRNA screens, probably as these receptors were essential for
virus entryinthe twostudies usingHeLacell lines[8,10], whereasin
the third study, CD4 and CXCR4 were not identified, presumably
because an engineered mechanism for viral entry was employed [9].
There is little support for proteins involved in MAP kinase or
PI3K-mediated intracellular signaling among global siRNA data
sets. We find no HDFs that are GO annotated as having MAP
kinase activity and just one HDF with lipid kinase activity
(phosphatidylinositol-4-phosphate 5-kinase type-1-c), though we
find two HDFs with PKC activity (PKC-g and serine/threonine-
protein kinase N2). These findings indicate that knock-downs of
single proteins from these cascades are generally insufficient to
significantly inhibit HIV-1 replication. However, we surmise these
central cascades are able to maintain signal transduction through
multiple routes, with the KEGG representation of the MAP kinase
cascade supporting this possibility [90–92]. Furthermore, HIV-1
interaction with these cascades is largely regulatory, rather than the
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one specific protein from a central signal transduction cascade, such
as a particular MAP kinase, for HIV-1 replication. Yet transduction
of virally induced signals through the host cell is almost certainly an
important mechanism in the proliferation of HIV-1.
We do not find that the subsystem annotations of any of cytokine
activity, interleukin, interferon-c and nuclear factor subsystems represent
statistically significant sets among HDFs. However, among HDFs,
we do find five genes that are designated by GO as having
cytokine activity including IL-1, chemokine-like factor, two
additional interleukins (IL-18 and IL-22) and Interferon-related
developmental regulator 2. These results indicate some cytokines
and chemokines are likely to enhance HIV-1 replication.
However, in our results cytokines form a far larger and more
prominent set of host proteins and interactions. We suggest that
this disparity is because while in vivo cytokines play a key part in
modulation of viral replication, by providing a pool of cells for
infection [93], immune system activation via cytokine release may
not be essential for viral replication within any given cell. Indeed,
in vitro, HIV-1 regulation of cytokines is likely to be of diminished
importance as there is no functional acquired or innate immune
system for the virus to interact with, either for the purpose of
evasion or hyper-stimulation. Furthermore, small scale in vitro
studies that have been explicitly designed to test the significance of
HIV-1 protein interactions with cytokines and in vitro siRNA
screens that test for HIV-1 dependence on host factors on a global
scale, are unlikely to reach the same conclusion, regarding the
relevance of cytokines to HIV-1 infection. The diminished
importance of cytokines among HDFs is also indicated by the
lack of support for the NFATs that promote cytokine transcription.
Innate cellular immune responses, such as APOBEC activity,
the interferon system and TRIM22-induced interferon activation
will be important in vitro [94–97]. Though as these innate immune
factors exert a negative effect on HIV-1 replication, they are
unlikely to be highlighted among HDF sets.
Conclusion
By capturing the published knowledge of HIV-host interactions,
the HHPID represents a hugely valuable resource for HIV-1
research. However, redundancy and heterogeneity of the PPI data,
in terms of experimental methods, age of findings and quality of
data, make the HHPID a difficult data set from which to draw
conclusions about the overall system of HIV-1 infection, such as
the identification of specific host functions and processes that are
essential for HIV-1 replication. Using the strategy presented here,
we identify significant patterns of HIV-host interaction, defined as
sets of host proteins that take part in similar, enriched
combinations of interactions during the course of HIV-1 infection.
We have confirmed that these host protein sets, linked by their
HIV-1 interaction profiles, are biologically related, tending to
include proteins with common biological processes, proteins that
share a high number of interactions with one another, subunits of
the same complex and paralogs. In addition, we find that by
identifying significant interaction patterns, we select for higher-
confidence, well-studied interactions, based on the number of
supporting journal articles. Hence, the identified higher-level
groups, based on shared interactions, represent significant cellular
subsystems used by HIV-1. Notably, our method incorporates the
biological action of each PPI. Therefore, unlike other studies that
identify cellular subsystems important to HIV-1 [1,9,11], the
subsystems presented here, respect specific activity-related patterns
of viral perturbation.
By assessing these subsystems using scientific literature and
support from three global siRNA screen HDF sets, we have been
able to describe systems of interaction that are invoked by HIV-1
to hijack host functions in order to successfully replicate including
virus entry, mechanisms for viral gene transcription, export of viral
RNA from the nucleus, viral budding and control of the
proteasome. In addition, we also highlight mechanisms through
which HIV-1 infection perturbs host processes at multiple cellular
levels through a cycle of interactions that are not necessarily
essential for viral replication, and appear detrimental to the
human host by damaging the host immune response through
dysregulation of cell surface receptor mediated signaling, signal
transduction pathways, host gene expression, cytokine release and
cell death.
Our approach permits a detailed study of the overlap between
significant patterns of HIV-host interaction in the HHPID and
HDFs. The modest overlap may be attributed to the fundamental
difference in the methods of construction between the source data
sets. The siRNA screens do not explicitly identify host cell proteins
that undergo direct physical interactions with the proteins of HIV-
1 or whose expression is altered during HIV-1 infection, as with
many of the host cell proteins given in the HHPID. Rather, these
screens are designed to identify host-cellular proteins that are
required by the virus for replication. Therefore, HDF sets will not
necessarily capture host proteins that are misregulated during
HIV-1 infection, i.e., may perturb normal cellular responses, or
host proteins that are potentially detrimental to HIV-1 infection,
such as APOBEC3G [94]. In addition, each study has its own
intrinsic bias. Particularly, the HHPID will be subject to study bias
[98], where aspects of perceived medical importance, such as T
cell depletion, receive greater attention. Whereas methods
employed in each siRNA screen will be better tailored to picking
certain host proteins over others. For example, one siRNA screen
was specifically designed to discover host factors involved in the
early stages of HIV-1 replication [9], while another used a viral
strain that expresses a truncated Vpr protein and does not express
Nef or Vpu [8]. In addition, the stage in the viral life cycle is also
likely to be an important factor in determining the activation of
PPI modules in the host cell [99], therefore, not all studies may
capture the same results. Hence, the lack of overlap between these
small and global-scale data sets is not unexpected.
The direct intersection between any one HDF set and the
HHPID probably represents a small set of high-confidence HIV-1
interacting host proteins important to HIV-1 replication. Howev-
er, analysis of this intersection alone is unlikely to provide a
thorough insight into host defense mechanisms, perturbations
caused by HIV-1 infection, or proteins that are essential to virus
replication. We suggest that future experimental work could
expand the core knowledge presented here. In particular, we
suggest that proteins and pathways that are indicated by siRNA
screen to be essential for HIV-1 replication, though otherwise
poorly understood, are studied in greater detail to continue to
bridge the knowledge gap between high and low throughput data
sources. A successful example of this approach is conformation of
TNPO3 as an essential protein for HIV-1 PIC import [83,84] after
initial identification as an HDF by [8,9].
The HHPID data set has been used previously to validate HDF
sets. Specifically HHPID interactions and host factors have been
used in conjunction with HDFs to aid identification of well-
connected subnetworks, corresponding to certain host cell
functions prevalent among HDFs [9,11]. Several of these
subnetworks represent functions identified in our results including
the proteasome and transcriptional regulation. However, we are
not aware of any other work in which core host cell functions,
represented in HHPID data, have been assessed in terms of their
presence among HDFs.
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disentangle a complex set of interactions to provide an accessible
map of core HIV-1-host interaction patterns for virologists. Our
methodology can be generalised and take PPI data from any
source. Hence, our work will contribute to defining core host
subsystems for other pathogens, particularly as a reference against
which results from increasingly prevalent high-throughput data
sources might be compared. In addition, aiding prediction of
currently undiscovered host-virus PPIs using interaction profiles
may be possible. This could be done by taking the interaction
profile of a given human protein, i.e., a ‘subject profile’, and
comparing it with interaction profiles from other human proteins,
i.e., a set of ‘query profiles’ to look for common interactions that
are missing for the subject profile that are common to many other
similar profiles (the distance measure in our work would be a
method to quantify this commonality). However, this would form
just part of such a prediction process and other established
biological phenomena that impact upon PPI activity, such as
interaction interfaces and cellular localisation, would also have to
be considered to make successful predictions. Notably, our results
and the potential predictive power to which we refer, are reliant
upon an accessible and structured description of biological action
for each PPI, as supplied in the HHPID. We have, thus,
demonstrated that the inclusion of concise annotation in large-
scale data can enhance resolution and allow greater depth of
computational analysis.
Materials and Methods
Data collection
HIV-human PPI data were obtained from the HHPID on 1st
May 2009. Specifically, distinct PPIs based upon: (i) the HIV-1
protein interactant, (ii) the human protein interactant and (iii) the
type of interaction, one of 68 short descriptions that characterise
the PPI outcome, were obtained [4,5]. In cases where multiple
transcripts of the same gene take part in the same interaction (with
respect to HIV-1 protein and interaction type), only a single
instance of the transcribed gene and interaction were used
throughout our analyses.
To test whether interaction types are uniformly distributed
among HIV-1 proteins, interaction types for each HIV-1 protein
were counted and p-values were calculated using two-tailed
Fisher’s exact tests and corrected for multiple tests using the
Benjamini and Hochberg [100] method.
Bicluster identification
In order to perform biclustering, a binary matrix was created
with one row per human protein and one column per HIV-1
interaction. We define an HIV-1 interaction to include both the
HIV-1 interactant and the interaction type, e.g., ‘capsid activates’
is one such interaction. The presence of a given HIV-1 interaction,
for a given protein, was represented in the matrix by a one and the
absence by a zero (figure 2). To find sets of human proteins that
share the same set of HIV-1 interactions in this matrix,
biclustering was performed using the Bimax algorithm [101].
The significance of biclusters was determined by Monte Carlo
simulation. Specifically, the HIV-human PPI network was rewired
at random, while the degree of each protein and interaction type
frequencies were maintained. The resulting network was used to
produce a new matrix for biclustering. The matrix was biclustered
using Bimax and interaction types, HIV-1 proteins and the
number of human proteins in each bicluster were recorded.
50 000 iterations of this process were carried out. Using these
simulations, we were able to empirically calculate the probability
of randomly finding a bicluster involving a given number of
human proteins and the same (or larger) set of HIV-1 interactions.
Biclusters were deemed significant if they had a p-value of
v0:001, after correction for multiple tests using the Benjamini
and Hochberg [100] method.
Bicluster classification
All interaction types from the HHPID were organised into a
hierarchy (see supplementary Text S1). This hierarchy included
new parent terms. For example, a parent term ‘physical’ was
created, the child terms of which all refer to more specific forms of
physical interaction. In addition, every interaction was designated
a direction, polarity and control. Direction refers to whether it is the
HIV-1 protein acting upon the human protein or vice versa, e.g.,
‘Tat inhibits p53’ has a forward direction, ‘Tat is inhibited by p53’
has a backward direction and ‘Tat interacts with p53’ has a neutral
direction. Polarity refers to the biological action of the interaction,
e.g., ‘Vpr activates p53’ has a positive polarity, ‘Vpr inhibits p53’
has a negative polarity and ‘Vpr interacts with p53’ has a neutral
polarity. Control refers to regulation within the interaction,
additional to the polarity, e.g., ‘Tat decreases phosphorylation of
retinoblastoma 1’ has a positive polarity but due to the verb
‘decrease’ has a negative control, while ‘Tat increases phosphor-
ylation of retinoblastoma 1’ has a positive control. For those
interaction types with no additional control, we set control as null.
This information was used to classify biclusters according to the
hierarchical relationship between their interactions. We defined three
types of relationship between interactions: two positive relationships,
parental and sibling, and one non-relationship, independence.
Positive relationships refer to the same biological event within a
given interaction, described using a different and perhaps more, or
less specific term. Independence, denotes that two interactions
describe distinct events, both providing additional information.
For any two interactions to be part of a positive relationship,
they must link the same two protein interactants, their directions
must not be opposing, i.e., forward and backward, their polarities
must not be opposing and the control must be the same. Parental
interaction relationships are formed when one interaction is the
descendant of another, e.g., ‘Tat binds p53’ is a descendant of the
interaction ‘Tat interacts with p53’. Sibling interaction relation-
ships are formed when both interactions have the same direct
parent term, e.g., ‘Tat activates Cdk2’ is a sibling of ‘Tat enhances
Cdk2’, as the parent term for both interaction types is ‘protein
regulation’. Interaction pairs that do not conform to parental or
sibling relationships have an independent relationship. These
relationship classifications give rise to five classes of bicluster: (i)
Independent, where all interactions have independent relationships.
(ii) Parental, where all of the interactions are descendants of one
another. (iii) Sibling, where two or more interactions are siblings of
one another in the ontology, e.g., ‘Tat activates Cdk2’ is a sibling
of ‘Tat enhances Cdk2’ (iv) Family, where all of the interactions
form a ‘family’ of parental and sibling relationships. (v) Mixed,
where independent interactions and sibling or parental interac-
tions form a bicluster.
Bicluster biological validation
We established a group of 692 proteins from the HIV-1
interacting set that could appear in the bicluster results. These
proteins are limited to those that have more than one distinct
HIV-1 interaction. This set of proteins are important to our
statistical analyses and will be referred to as potential bicluster
proteins (PBPs).
A human PPI network was created using protein interactions
derived from multiple sources: BioGRID [102], BIND [103] and
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‘gene_info’ file provided by the Entrez Gene database (ftp://ftp.
ncbi.nlm.nih.gov/gene) to maintain consistent accession labeling.
Thesedatasets were obtainedinJuly2009. ThehumanPPI network
contained only one node per human gene, a maximum of one edge
between two nodes and a total of 9000 nodes and 30478 edges.
The number of shared edges, average shortest path length and
largest connected component (LCC) for the set of human protein
nodes defined by each significant bicluster were calculated from this
network and statistical significance was calculated by Monte Carlo
simulation. In a single iteration of this simulation, a group of nodes
numbering the same as the bicluster in question were selected at
random using rejection sampling in order to maintain the group
degree distribution. Following this, shared edge count, average
shortest path length and LCC were recorded. 10000 iterations of
this simulation were carried out per bicluster. The results of the
simulation were used to estimate the probability that a more tightly
clustered set of nodes, of given size and degree distribution would be
found by random chance, p-values were corrected for multiple tests
using the Benjamini and Hochberg [100] method.
To analyze similarity between proteins within biclusters, we
performed local protein sequence alignments between all PBPs
using the Smith-Waterman algorithm [105] with a gap open cost
of 10, a gap extension cost of 0.1 and the BLOSUM62 substitution
matrix. To analyze similarity in annotation between proteins
within biclusters, we carried out a semantic similarity measure-
ment [106] between all PBPs using GO annotation for all three
ontologies: molecular function, biological process and cellular
component. The GO data was downloaded from the Gene
Ontology on the 9th December 2008. We defined the distance
between two genes using the method given in [26], using the
semantic distance measurement defined in [106]. For both of these
measures we compared the value distribution for protein pairs that
appear in the same significant bicluster to the equivalent
distribution for proteins that do not appear in the same significant
bicluster using a Mann-Whitney U test. We also calculated p-
values for each significant bicluster, for both of these measures,
using Monte Carlo simulations. For a given bicluster of size n and
a mean average alignment score, or semantic similarity, s, 100000
and 10000 simulation iterations, for the pairwise alignment and
semantic similarity simulations, respectively, were performed. In
each iteration we selected a non-redundant random set of n
proteins from PBPs and calculated the average alignment score or
semantic similarity and counted whether this value was greater
than, or less than s. By this method we were able to calculate the
probability of finding a set of proteins, by random chance, with
greater similarity than the proteins of a bicluster, both in terms of
sequence and GO annotation. We corrected the p-values for
multiple tests using the Benjamini and Hochberg [100] method. In
addition, we identified groups of similar human protein sequences
within significant biclusters using single-linkage clustering; linking
pairs of proteins that have w40% sequence identity, determined
by sequence alignments and selecting connected components.
Defining subsystems
The distance between any two biclusters, a and b, was
calculated using the formula:
da ,b ðÞ ~1{
2|DA\BD
DADzDBD
Where A and B are the set of interactions in biclusters a and b,
DAD and DBD are the number of interactions in sets A and B and
DA\BD is the size of the intersection between sets A and B.
Therefore, for two identical biclusters da ,b ðÞ ~0, while for two
biclusters that have no common interactions da ,b ðÞ ~1. Distances
between all biclusters were calculated, cubed to obtain a greater
range of values and the resulting distances were used to define
relationships between biclusters using neighbor joining [37].
Meaningful groups were determined, by examining bicluster
proteins and interactions. These groups were characterised and
named using one of the following two methods: (i) Selecting one or
more over-represented GO term (pv0:001), calculated using
Fisher’s exact tests corrected for multiple tests using the Benjamini
and Hochberg [100] method. (ii) In the case where the proteins of
a subgroup are all homologs or isoforms of the same product and
no specific GO term pertaining to that protein product exists, a
regular expression encapsulating the protein name was used to
characterise the group and that group was named after the
protein. The method used to define each group is specified in
supplementary Table S3.
Comparison with siRNA screen data
Proteins from three siRNA studies [8–10], were cross referenced
against the identified host subsystems. These studies include 281
[8], 295 [9] and 290 [10] genes. The genes not expressed in T cells
or macrophages, designated group ‘H’ in one study (reference
[10]) were not included. The number of successful hits against
each subsystem and the direct intersection was counted for each of
the three studies and p-values for these counts were calculated
using chi-square tests, using all genes annotated in the gene
ontology as the population, corrected for multiple tests using the
Benjamini and Hochberg [100] method. HIV-1-host PPI networks
were constructed and visualised using Cytoscape [107].
Supporting Information
Table S1 Table of significant biclusters and their HIV-host
interactions. A table of significant biclusters. Each row represents a
single HIV-host interaction within a significant bicluster. The
biclusters are divided in to higher-level groups, known as sub-systems,
based on shared interactions and labeled according to the biological
role of the included host proteins. From right to left, the columns
show: name of the sub-system; bicluster id; p-value for the bicluster;
corrected p-value, calculated using the Benjamini and Hochberg
FDR correction method; entrez gene id corresponding to the human
protein interactant; name of the human protein interactant; entrez
gene id corresponding to the HIV-1 protein interactant; a string
identifier for the interaction type, consisting of a short HIV-1 protein
name and a description of the interaction outcome, separated by an
underscore; the relationship of that interaction to other interactions
within the same bicluster; id for the corresponding interaction in the
HHPID; the HHPID description of the interaction.
Found at: doi:10.1371/journal.pcbi.1000863.s001 (2.80 MB XLS)
Table S2 Table of biological cohesiveness measures for
significant biclusters. A table of biological cohesiveness measures.
Each row represents a significant bicluster. Sequence similarity,
semantic similarity and network clustering are measures pertaining
to the proteins of a given bicluster. From right to left, the columns
show: bicluster id; p-value for sequence similarity; corrected p-
value for sequence similarity, calculated using the Benjamini and
Hochberg FDR correction method; number of proteins found in
the largest protein cluster, within that bicluster, determined by
single linkage clustering, using a linkage cut-off of 40% sequence
similarity; as in the latter but using a cut-off of 80% sequence
similarity; p-value for human PPI network shared edge count;
corrected p-value for human PPI network shared edge count,
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method; p-value for human PPI network largest connected
component; corrected p-value for human PPI network largest
connected component, calculated using the Benjamini and
Hochberg FDR correction method; p-value for human PPI
network average shortest path length; corrected p-value for human
PPI network average shortest path length, calculated using the
Benjamini and Hochberg FDR correction method; p-value for
semantic similarity using the GO biological process ontology;
corrected p-value for semantic similarity using the GO biological
process ontology, calculated using the Benjamini and Hochberg
FDR correction method; p-value for semantic similarity using the
GO cellular component ontology; corrected p-value for semantic
similarity using the GO cellular component ontology, calculated
using the Benjamini and Hochberg FDR correction method;
p-value for semantic similarity using the GO molecular function
ontology; corrected p-value for semantic similarity using the GO
molecular function ontology, calculated using the Benjamini and
Hochberg FDR correction method.
Found at: doi:10.1371/journal.pcbi.1000863.s002 (0.09 MB XLS)
Table S3 Table of host subsystem details. A table of host
subsystem details. Each row represents a host subsystem. From right
to left the columns show: the name of the subsystem; the number of
biclusters included in the subsystem; the number of human genes in
the subsystem; the intersection between the subsystem and the Brass
et al. (2008) siRNA screen; p-value for the latter; corrected p-value
for the latter, calculated using the Benjamini and Hochberg FDR
correction method; the intersection between the subsystem and the
Konig et al. (2008) siRNA screen; p-value for the latter; corrected p-
value for the latter, calculated using the Benjamini and Hochberg
FDR correction method; the intersection between the subsystem
and the Zhou et al. (2008) siRNA screen; p-value for the latter;
corrected p-value for the latter, calculated using the Benjamini and
Hochberg FDR correction method; the type of subsystem
annotation used to identify the subsystem; the details of the
subsystem annotation; the number of human genes from the sub-
system that fit the subsystem annotation; the p-value for the
subsystem annotation; a corrected p-value for the subsystem
annotation, calculated using the Benjamini and Hochberg FDR
correction method; number of genes from the Brass et al. (2008)
siRNA screen that fit the subsystem annotation; p-value for the
latter; corrected p-value for the latter, calculated using the
Benjamini and Hochberg FDR correction method; number of
genes from the Konig et al. (2008) siRNA screen that fit the subsystem
annotation; p-value for the latter; corrected p-value for the latter,
calculated using the Benjamini and Hochberg FDR correction
method; number of genes from the Zhou et al. (2008) siRNA screen
that fit the subsystem annotation; p-value for the latter; corrected p-
value for the latter, calculated using the Benjamini and Hochberg
FDR correction method.
Found at: doi:10.1371/journal.pcbi.1000863.s003 (0.04 MB XLS)
Text S1 Hierarchy of protein interaction types. A hierarchy that
incorporates all of the interaction types found in the NCBI HIV-1,
host protein interaction database (HHPID) with the addition of
parent terms for these types. HHPID interaction types have a
unique id, and polarity, direction and control attributes. These
attributes are explained in detail in the methods section in the
main text of this article. Interaction types found in the HHPID are
present as instance elements, parent terms are designated as
interactionType elements.
Found at: doi:10.1371/journal.pcbi.1000863.s004 (0.01 MB
XML)
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